Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-02
1996-09-17
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514210, 5142362, 514299, 514326, 514342, 544134, 546183, 546209, 548135, C07D28510, A61K 3141
Patent
active
055569099
ABSTRACT:
Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives, pharmaceutical compositions containing them and methods for the treatment of degenerative diseases utilizing them.
REFERENCES:
patent: 5128339 (1992-07-01), Dunlap et al.
patent: 5236917 (1993-08-01), Dunlap et al.
patent: 5306818 (1994-04-01), Subramanyam et al.
Cha, Biochem. Pharmacol., 1975, 24, 2177-2185.
Groutas et al., Biochemical and Biophysical Research Communications 1994, 198(1), 341-349.
Muller and DuBois, J. Org. Chem. 1989, 54, 4471-4473.
Lee et al., J. Org. Chem. 1989, 54, 3077-3083.
Lee and Kohn, Journal of Pharmaceutical Sciences 1990, 79(8), 716-718.
Hanewacker et al., Arch. Pharm. 1993, 326, 497-498.
Unterhalt and Hanewacker, Arch. Pharm. 1988, 321, 375-376.
Unterhalt and Hanewacker, Arch. Pharm. 1988, 321, 749-751.
Aouf et al., Tetrahedron Letters 1991, 32(45), 6545-6546.
Dewynter et al., Tetrahedron 1993, 49(1), 65-76.
Davis William J.
DuPont Paul E.
Gerstl Robert
Sanofi Winthrop Inc.
LandOfFree
Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-413770